Adler & Co.
2
11M
2
0.09
1
1
- Areas of investment
Summary
Adler & Co. appeared to be the Corporate Investor, which was created in 1998. The main office of represented Corporate Investor is situated in the Westminster. The fund was located in North America if to be more exact in United States.
Among the various public portfolio startups of the fund, we may underline Courtagen Life Sciences, MedCases For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of more than 20 years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Health Diagnostics.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Adler & Co., startups are often financed by Harbor Light Capital Partners. The meaningful sponsors for the fund in investment in the same round are Novitas Capital, Harbor Light Capital Partners, First Analysis.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2015. The top amount of exits for fund were in 2006.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.09
- Investments by industry
- Health Diagnostics (1)
- Genetics (1)
- Life Science (1)
- Biotechnology (1)
- Internet (1) Show 2 more
- Investments by region
-
- United States (2)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 36
- Group Appearance index
- 1.00
- Avg. company exit year
- 35
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| MedCases | 12 May 2000 | Internet, Education, Medical | Early Stage Venture | 3M | United States, New Jersey |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.